EUVIMEDEUVIMED entdecken
ÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte Studie

Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus

Tim Hundscheid iD, Wes Onland, Elisabeth M W Kooi, Daniel C Vijlbrief, Willem B de Vries, Koen P Dijkman, Anton H van Kaam, Eduardo Villamor, André A Kroon, Remco Visser, Susanne M Mulder-de Tollenaer, Barbara De Bisschop und 15 weitere

New England Journal of Medicine · 16.03.2023 · 388 (11) · 980-990

DOI: 10.1056/nejmoa2207418 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift New England Journal of Medicine, erschienen am 16.03.2023. Verfasst von Tim Hundscheid und 26 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Pediatrics, Division of Neonatology (T.H., W.P.B.), and the Department for Health Evidence (R.D.), Radboud University Medical …. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Ductus Arteriosus, Patent, Enterocolitis, Necrotizing, Ibuprofen. Die Arbeit wurde bisher 217-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Belgian Health Care Knowledge Centre, ZonMw, KCE, the Belgian Health Care Knowledge Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchopulmonary DysplasiaDuctus Arteriosus, PatentEnterocolitis, NecrotizingIbuprofenWatchful WaitingHumansInfantInfant, NewbornEchocardiographyIndomethacinInfant, Extremely PrematureInfant, Low Birth WeightInfant, Newborn, Diseases

Substanzen

IbuprofenIndomethacin

Autor:innen und Institutionen

  • From the Department of Pediatrics, Division of Neonatology (T.H., W.P.B.), and the Department for Health Evidence (R.D.), Radboud University Medical Center, Radboud Institute for Health Sciences, Amalia Children's Hospi…

ORCID-Profile: Tim Hundscheid, Daniela Avino

Förderung

  • Belgian Health Care Knowledge Centre
  • ZonMw
  • KCE, the Belgian Health Care Knowledge Center

Zitieren

APA

Hundscheid, T., Onland, W., Kooi, E. M. W., Vijlbrief, D. C., de Vries, W. B., Dijkman, K. P., van Kaam, A. H., Villamor, E., Kroon, A. A., Visser, R., Mulder-de Tollenaer, S. M., De Bisschop, B., Dijk, P. H., Avino, D., Hocq, C., Zecic, A., Meeus, M., de Baat, T., Derriks, F., …, & BeNeDuctus Trial Investigators (2023). Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. New England Journal of Medicine, 388(11), 980-990. https://doi.org/10.1056/nejmoa2207418

Vancouver

Hundscheid T, Onland W, Kooi EMW, Vijlbrief DC, de Vries WB, Dijkman KP, et al. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. New England Journal of Medicine. 2023;388(11):980-990. doi:10.1056/nejmoa2207418

BibTeX
@article{Hundscheid2023,
  author = {Hundscheid, Tim and Onland, Wes and Kooi, Elisabeth M W and Vijlbrief, Daniel C and de Vries, Willem B and Dijkman, Koen P and van Kaam, Anton H and Villamor, Eduardo and Kroon, André A and Visser, Remco and Mulder-de Tollenaer, Susanne M and De Bisschop, Barbara and Dijk, Peter H and Avino, Daniela and Hocq, Catheline and Zecic, Alexandra and Meeus, Marisse and de Baat, Tessa and Derriks, Frank and Henriksen, Tine B and Kyng, Kasper J and Donders, Rogier and Nuytemans, Debbie H G M and Van Overmeire, Bart and Mulder, Antonius L and de Boode, Willem P and BeNeDuctus Trial Investigators, BeNeDuctus Trial Investigators},
  title = {Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {388},
  number = {11},
  pages = {980--990},
  doi = {10.1056/nejmoa2207418}
}
Kostenlos starten →